The Robert M. Scarborough Award for Excellence in Medicinal Chemistry

The Robert M. Scarborough Award for Excellence in Medicinal Chemistry, given in even-numbered years, is intended to recognize individuals who have had primary, leading roles in the discovery of novel therapeutic agents or who have otherwise made significant scientific discoveries that enhance the field of medicinal chemistry. This award is in memory of Robert M. Scarborough, an accomplished medicinal chemist and inventor of drugs such as Natrecor® and Integrilin®. The award is sponsored by Portola Pharmaceuticals, Inc., a cardiovascular company founded by Dr. Scarborough. The awardee will present an award address at the Fall national meeting of the American Chemical Society as a part of Division of Medicinal Chemistry programming, and receive a commemorative plaque, a honorarium of $8,000 at the symposium, and travel expenses incidental to receiving the award at the Fall National Meeting on even-numbered years. Nominees can be employed in industry, academia, government or a private research foundation and must have documented success in the discovery of pharmaceutical entities and/or a substantial body of significant research contributions in medicinal chemistry. Candidates should have a significant record of productivity as measured by the number and quality of scientific publications and issued patents. Nominees are expected to have demonstrated creativity and insight in medicinal chemistry and/or biology and employ pragmatic, empirical problem solving skills.